The practical guide to supplement recommendations in practitioner online programs in Australia (2026)

Online programs and evergreen courses have become one of the most scalable ways for Australian health practitioners to grow their practice beyond the one-to-one consultation model. The appeal is obvious: education runs 24 hours a day, reaches people who cannot access in-person care, and generates recurring revenue without adding clinical hours.

The compliance question that follows is equally obvious: where does general education end and personalised advice begin — and what are the consequences of getting that line wrong?

This is not a theoretical question. The TGA issued 147 infringement notices totalling $2.20M in 2023–24. AHPRA assessed 775 advertising complaints in 2024–25 — up 104% in two years. Practitioners running online programs are not exempt from either framework. The advertising rules that apply to a clinic website apply equally to an online course platform, a sales page, or a decision tree that directs participants toward named products.

The most useful way to think about an online practitioner program is not as a course. It is as a funnel. And the mistake most practitioners make when designing these programs is trying to deliver a bottom-of-funnel outcome — a personalised product recommendation — right at the top, before any meaningful clinical interaction has taken place.

The level of personalisation you can offer at each stage of a program is directly capped by the level of interaction you have earned at that stage.

Top of funnel — general education: This is where evergreen content lives. General information about nutrients, herbs, mechanisms of action, and evidence-based applications is permissible without a consultation. The constraint is specificity: general categories are permissible, named products at therapeutic doses are not. "Magnesium supports muscle relaxation and sleep quality" is education. "Take 300mg of this specific magnesium glycinate product if you have these symptoms" is a recommendation — and it requires a consult first.

Middle of funnel — the consult: This is where the real clinical work sits. Screening for red flags, contraindications, drug-nutrient interactions, and individual health history cannot be replaced by a questionnaire. The duty of care obligation for Australian health practitioners — registered and unregistered — requires that personalised recommendations are preceded by adequate clinical assessment. The Code of Conduct for Unregistered Health Practitioners — enacted in NSW, QLD, SA, VIC, WA, ACT, and TAS (not yet operating in the NT) — reinforces this independently of AHPRA obligations.

Bottom of funnel — the recommendation: Named products, specific doses, and practitioner-only ranges belong here — after the consult, never before it. This applies equally to OTC products. The funnel does not change the rule; it just clarifies when the rule applies.

A questionnaire is a tool for narrowing the funnel. It qualifies participants, identifies general categories of need, and routes people toward the next appropriate stage. It is not a shortcut around the consultation.

This distinction matters for two reasons.

First, under the TGA Advertising Code 2021 s.24, a practitioner cannot make a product endorsement or recommendation about therapeutic goods without it being grounded in appropriate clinical assessment. A decision tree that says "if you have these symptoms, take this product" is a product recommendation — regardless of whether it is automated, embedded in a course platform, or framed as educational content.

Second, under the Australian Consumer Law s.18, representations about therapeutic goods must not be misleading. A questionnaire that implies it can substitute for a clinical assessment — and that the product recommendations that follow are equivalent to personalised advice — creates a misleading representation about the nature of the service being provided.

The compliant use of a questionnaire in an online program is this: it points participants toward general information categories and routes them into a consult for personalised recommendations. It qualifies people; it does not advise them.

The practitioners who run the most commercially successful online programs have largely solved this problem through what is commonly called a hybrid or evergreen model.

The structure is straightforward:

• Evergreen top-of-funnel content runs continuously — general education on nutrients, herbs, mechanisms, and lifestyle factors. No named products, no personalised doses, no clinical recommendations.
• A qualification mechanism — typically a questionnaire or intake form — narrows participants to relevant categories and surfaces red flags that require clinical attention before proceeding.
• Mini-consults or check-in calls sit in the middle of the program — short, structured clinical touchpoints that allow for contraindication screening, interaction checking, and the earning of the clinical relationship required to make a personalised recommendation.
• Product recommendations — including OTC and practitioner-only ranges — are delivered after the consult, either through a separate consult report or a personalised module unlocked after the clinical touchpoint is completed.

This model allows education to scale without limit. It routes people toward personalised recommendations at the pace the practitioner can clinically support. And it keeps the program inside the duty of care framework at every stage.

Disclaimers are not a compliance strategy. They are a risk mitigation layer on top of a compliant program structure — not a substitute for one.

A disclaimer that says "this is general information only and does not constitute personalised advice" is appropriate and necessary for the top-of-funnel educational content of a program. It signals to participants that what they are receiving is education, not a clinical recommendation.

A disclaimer applied to content that is, in substance, a personalised product recommendation — regardless of how it is framed — does not change the nature of that content under Australian Consumer Law or the TGA Advertising Code. If a decision tree directs a participant toward a named product based on their symptom profile, a disclaimer does not reclassify that as general information.

The disclaimer protects the top of the funnel. The consult protects the bottom.

For legal advice specific to course terms and conditions, participant consent frameworks, and disclaimers appropriate to your modality, practitioners should consult a health law specialist familiar with the Australian regulatory environment.

CompliGUARD provides compliance infrastructure, not legal advice. Regulatory responsibility rests solely with the advertiser or practitioner. compliguard.com.au

• Publishing without checking the complete advertisement’s overall impression.
• Treating one regulator’s checklist as coverage for every applicable framework.
• Failing to retain evidence showing what was reviewed and approved before publication.

CompliGUARD reviews the complete advertisement against TGA · AHPRA · FSANZ · ACCC requirements, identifies clause-level risks, proposes compliant wording, and retains the result in an audit trail before publication.